Credit Markets Gain Prominence in the Biotech Industry Biotech companies raised over $34 billion through debt financing in 2023. 2022 marked a significant shift in the biotech industry’s financial landscape. The sector experienced a 54% annual decrease in available capital compared to the previous two years of heightened financing. The IPO scene, particularly in the...Read More
Issuance of investment-grade bonds by U.S. companies rose above $191 billion in January. This was the highest recorded level of activity in January. Including the high-yield and convertible bonds, the issuance in the month crossed $223 billion. Most of the new issuances are related to refinancing. New records expected in 2024 BofA Global estimates the...Read More
